UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation

Cell metabolism, 2017-10, Vol.26 (4), p.633-647.e7

2017

Volltextzugriff (PDF)

Influence of Sex in the Molecular Characteristics and Outcomes of Malignant Tumors

Frontiers in oncology, 2021-10, Vol.11, p.752918-752918

2021

Volltextzugriff (PDF)

Patterns of Mutation Enrichment in Metastatic Triple-Negative Breast Cancer

Clinical Medicine Insights. Oncology, 2019, Vol.13, p.1179554919868482-1179554919868482

2019

Volltextzugriff (PDF)

Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer

Nature communications, 2019-03, Vol.10 (1), p.1373-1373, Article 1373

2019

Volltextzugriff (PDF)

Activation of MAPK Pathways due to DUSP4 Loss Promotes Cancer Stem Cell-like Phenotypes in Basal-like Breast Cancer

Cancer research (Chicago, Ill.), 2013-10, Vol.73 (20), p.6346-6358

2013

Volltextzugriff (PDF)

Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER + Breast Cancer

Clinical cancer research, 2017-10, Vol.23 (20), p.6138-6150

2017

Volltextzugriff (PDF)

Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence

Science translational medicine, 2016-04, Vol.8 (334), p.334ra53

2016

Volltextzugriff (PDF)

Extended Adjuvant Therapy with Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER + /HER2 + Breast Cancers: Implications to the ExteNET Trial

Clinical cancer research, 2019-01, Vol.25 (2), p.771-783

2019

Volltextzugriff (PDF)

An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand Overexpression

JNCI : Journal of the National Cancer Institute, 2017-11, Vol.109 (11)

2017

Volltextzugriff (PDF)

ER + Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors

Clinical cancer research, 2018-06, Vol.24 (11), p.2517-2529

2018

Volltextzugriff (PDF)

Helicobacter pylori: History and facts in Peru

Critical reviews in oncology/hematology, 2019-02, Vol.134, p.22-30

2019

Volltextzugriff (PDF)

LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer

The Journal of clinical investigation, 2014-12, Vol.124 (12), p.5490-5502

2014

Volltextzugriff (PDF)

Correction: ER + Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors

Clinical cancer research, 2019-02, Vol.25 (4), p.1431-1431

2019

Volltextzugriff (PDF)

Correction: Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER + Breast Cancer

Clinical cancer research, 2019-02, Vol.25 (4), p.1433-1433

2019

Volltextzugriff (PDF)

A nationwide pilot study on breast cancer screening in Peru

Ecancermedicalscience, 2023-01, Vol.17, p.1494-1494

2023

Volltextzugriff (PDF)

Precision medicine for locally advanced breast cancer: frontiers and challenges in Latin America

Ecancermedicalscience, 2019-01, Vol.13, p.896-896

2019

Volltextzugriff (PDF)

Maybe we don't know JAK?

Molecular & cellular oncology, 2016-07, Vol.3 (4), p.e1192713-e1192713

2016

Volltextzugriff (PDF)

Abstract 4818: Neratinib/fulvestrant but not fulvestrant alone maintain complete responses after treatment with trastuzumab/paclitaxel of mice bearing ER+/HER2+ xenografts

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4818-4818

2017

Volltextzugriff (PDF)

Abstract 1518: Gene expression profile and gender differences related with immune processes in solid tumors

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.1518-1518

2019

Volltextzugriff (PDF)

MYC and MCL1 cooperatively promote chemotherapy-resistant breast cancer stem cells through regulation of mitochondrial oxidative phosphorylation

Cell metabolism, 2017-10, Vol.26 (4), p.633-647.e7

2017

Volltextzugriff (PDF)

Abstract P6-03-03: Enrichment of janus kinase-2 (JAK2)-amplified tumor cell populations in triple-negative breast cancers (TNBC) during chemotherapy treatment

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P6-P6-03-03

2015

Volltextzugriff (PDF)

Desorden linfoproliferativo germinotrópico asociado al HHV8/KSVH y EBV

Interciencia médica, 2022-07, Vol.12 (2), p.38-46

2022

Volltextzugriff (PDF)

A diuranium carbide cluster stabilized inside a C80 fullerene cage

Nature communications, 2018-07, Vol.9 (1), p.1-8, Article 2753

2018

Volltextzugriff (PDF)

1 – 25 von 100

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(85)

Publikationsform

Sprache

Englisch
(98)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(67)
Life Sciences & Biomedicine
(42)
Humans
(30)
Female
(20)
Animals
(15)
Oncology
(14)
Technology
(14)
Physical Sciences
(13)
Computer Science
(12)
Male
(10)
Middle Aged
(10)
Breast Cancer
(9)
Mutation
(9)
Cell Line, Tumor
(8)
Mice
(8)
Aged
(7)
Breast Neoplasms - Drug Therapy
(7)
Clinical Trials
(7)
Computer Science, Artificial Intelligence
(7)
Tumors
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

MYC and MCL1 Cooperatively Promote Chemotherapy-Resistant Breast Cancer Stem Cells via Regulation of Mitochondrial Oxidative Phosphorylation

Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets

Influence of Sex in the Molecular Characteristics and Outcomes of Malignant Tumors

Patterns of Mutation Enrichment in Metastatic Triple-Negative Breast Cancer

Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer

Activation of MAPK Pathways due to DUSP4 Loss Promotes Cancer Stem Cell-like Phenotypes in Basal-like Breast Cancer

Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER + Breast Cancer

Triple-negative breast cancers with amplification of JAK2 at the 9p24 locus demonstrate JAK2-specific dependence

Extended Adjuvant Therapy with Neratinib Plus Fulvestrant Blocks ER/HER2 Crosstalk and Maintains Complete Responses of ER + /HER2 + Breast Cancers: Implications to the ExteNET Trial

An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand Overexpression

ER + Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors

Helicobacter pylori: History and facts in Peru

LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer

Correction: ER + Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors

Correction: Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER + Breast Cancer

A nationwide pilot study on breast cancer screening in Peru

Precision medicine for locally advanced breast cancer: frontiers and challenges in Latin America

Maybe we don't know JAK?

Abstract 4818: Neratinib/fulvestrant but not fulvestrant alone maintain complete responses after treatment with trastuzumab/paclitaxel of mice bearing ER+/HER2+ xenografts

Abstract 1518: Gene expression profile and gender differences related with immune processes in solid tumors

MYC and MCL1 cooperatively promote chemotherapy-resistant breast cancer stem cells through regulation of mitochondrial oxidative phosphorylation

Abstract P6-03-03: Enrichment of janus kinase-2 (JAK2)-amplified tumor cell populations in triple-negative breast cancers (TNBC) during chemotherapy treatment

Desorden linfoproliferativo germinotrópico asociado al HHV8/KSVH y EBV

A diuranium carbide cluster stabilized inside a C80 fullerene cage

Biological brain age prediction using machine learning on structural neuroimaging data: Multi-cohort validation against biomarkers of Alzheimer's disease and neurodegeneration stratified by sex

Suchergebnisse filtern